354 related articles for article (PubMed ID: 32571604)
21. Identifying patients with genetic predisposition to acute myeloid leukemia.
Obrochta E; Godley LA
Best Pract Res Clin Haematol; 2018 Dec; 31(4):373-378. PubMed ID: 30466750
[TBL] [Abstract][Full Text] [Related]
22. Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology.
Roloff GW; Drazer MW; Godley LA
JCO Precis Oncol; 2021 Nov; 5():107-122. PubMed ID: 34994594
[TBL] [Abstract][Full Text] [Related]
23. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
24. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
Drazer MW; Kadri S; Sukhanova M; Patil SA; West AH; Feurstein S; Calderon DA; Jones MF; Weipert CM; Daugherty CK; Ceballos-López AA; Raca G; Lingen MW; Li Z; Segal JP; Churpek JE; Godley LA
Blood Adv; 2018 Jan; 2(2):146-150. PubMed ID: 29365323
[TBL] [Abstract][Full Text] [Related]
25. Hematological Malignancies in Adults With a Family Predisposition.
Bochtler T; Haag GM; Schott S; Kloor M; Krämer A; Müller-Tidow C
Dtsch Arztebl Int; 2018 Dec; 115(50):848-854. PubMed ID: 30722840
[TBL] [Abstract][Full Text] [Related]
26. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
Homan CC; Drazer MW; Yu K; Lawrence DM; Feng J; Arriola-Martinez L; Pozsgai MJ; McNeely KE; Ha T; Venugopal P; Arts P; King-Smith SL; Cheah J; Armstrong M; Wang P; Bödör C; Cantor AB; Cazzola M; Degelman E; DiNardo CD; Duployez N; Favier R; Fröhling S; Rio-Machin A; Klco JM; Krämer A; Kurokawa M; Lee J; Malcovati L; Morgan NV; Natsoulis G; Owen C; Patel KP; Preudhomme C; Raslova H; Rienhoff H; Ripperger T; Schulte R; Tawana K; Velloso E; Yan B; Kim E; Sood R; Hsu AP; Holland SM; Phillips K; Poplawski NK; Babic M; Wei AH; Forsyth C; Mar Fan H; Lewis ID; Cooney J; Susman R; Fox LC; Blombery P; Singhal D; Hiwase D; Phipson B; Schreiber AW; Hahn CN; Scott HS; Liu P; Godley LA; Brown AL;
Blood Adv; 2023 Oct; 7(20):6092-6107. PubMed ID: 37406166
[TBL] [Abstract][Full Text] [Related]
27. Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.
Király AP; Kállay K; Gángó A; Kellner Á; Egyed M; Szőke A; Kiss R; Vályi-Nagy I; Csomor J; Matolcsy A; Bödör C
Pathol Oncol Res; 2018 Jan; 24(1):83-88. PubMed ID: 28357685
[TBL] [Abstract][Full Text] [Related]
28. Cancer predisposition syndromes associated with myeloid malignancy.
Quinn E; Nichols KE
Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
[TBL] [Abstract][Full Text] [Related]
29. Myeloid Neoplasms with Germline Predisposition: A New Provisional Entity Within the World Health Organization Classification.
Czuchlewski DR; Peterson LC
Surg Pathol Clin; 2016 Mar; 9(1):165-76. PubMed ID: 26940275
[TBL] [Abstract][Full Text] [Related]
30. Familial myelodysplasia and acute myeloid leukaemia--a review.
Owen C; Barnett M; Fitzgibbon J
Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
[TBL] [Abstract][Full Text] [Related]
31. Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations.
Mir MA; Kochuparambil ST; Abraham RS; Rodriguez V; Howard M; Hsu AP; Jackson AE; Holland SM; Patnaik MM
Cancer Med; 2015 Apr; 4(4):490-9. PubMed ID: 25619630
[TBL] [Abstract][Full Text] [Related]
32. Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications.
Kallen ME; Dulau-Florea A; Wang W; Calvo KR
Semin Hematol; 2019 Jan; 56(1):69-82. PubMed ID: 30573048
[TBL] [Abstract][Full Text] [Related]
33. Recognition of familial myeloid neoplasia in adults.
Brown AL; Churpek JE; Malcovati L; Döhner H; Godley LA
Semin Hematol; 2017 Apr; 54(2):60-68. PubMed ID: 28637618
[TBL] [Abstract][Full Text] [Related]
34. Discussing and managing hematologic germ line variants.
Kohlmann W; Schiffman JD
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):309-315. PubMed ID: 27913496
[TBL] [Abstract][Full Text] [Related]
35. Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities.
Trottier AM; Godley LA
Br J Haematol; 2021 Aug; 194(4):663-676. PubMed ID: 33615436
[TBL] [Abstract][Full Text] [Related]
36. Inherited predisposition to acute myeloid leukemia.
Godley LA
Semin Hematol; 2014 Oct; 51(4):306-21. PubMed ID: 25311743
[TBL] [Abstract][Full Text] [Related]
37. Pediatric Germline Predisposition to Myeloid Neoplasms.
Thompson C; Ariagno S; Kohorst MA
Curr Hematol Malig Rep; 2022 Dec; 17(6):266-274. PubMed ID: 36117229
[TBL] [Abstract][Full Text] [Related]
38. Recognizing familial myeloid leukemia in adults.
Nickels EM; Soodalter J; Churpek JE; Godley LA
Ther Adv Hematol; 2013 Aug; 4(4):254-69. PubMed ID: 23926458
[TBL] [Abstract][Full Text] [Related]
39. Advances in the recognition and management of hereditary cancer.
Kulkarni A; Carley H
Br Med Bull; 2016 Dec; 120(1):123-138. PubMed ID: 27941041
[TBL] [Abstract][Full Text] [Related]
40. Germline ETV6 mutations and predisposition to hematological malignancies.
Feurstein S; Godley LA
Int J Hematol; 2017 Aug; 106(2):189-195. PubMed ID: 28555414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
